BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180411
DTEND;VALUE=DATE:20180415
DTSTAMP:20260515T074215
CREATED:20171025T014409Z
LAST-MODIFIED:20180111T031457Z
UID:3596-1523404800-1523750399@www.pharmajournalist.com
SUMMARY:The Health Industry Summit(tHIS)
DESCRIPTION:The Health Industry Summit(tHIS) – EXPO and Congress is the umbrella global Pharmaceutical and Medical industry event in Asia\, the world’s fastest growing health market. It brings together CMEF\, PharmChina and API China in one place at the same time\,the only event providing complete coverage of the health industry.It enables leading academics and professionals from around the world to meet and share the latest innovation and thinking on policies & investment\, R&D\, Manufacturing & distribution\,education & hospital applications and related services for the industry. \n\nTo learn more about this event\, and to register online\, visit https://goo.gl/5qrDQX \n 
URL:https://www.pharmajournalist.com/event/health-industry-summit-this-2018/
LOCATION:National Exhibition and Convention Center (Shanghai)
ORGANIZER;CN="Reed Sinopharm Exhibitions":MAILTO:james.wang@reedsinopharm.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180411
DTEND;VALUE=DATE:20180413
DTSTAMP:20260515T074215
CREATED:20171128T075734Z
LAST-MODIFIED:20171128T075957Z
UID:4686-1523404800-1523577599@www.pharmajournalist.com
SUMMARY:Pre-Filled Syringes East Coast
DESCRIPTION:Enabling the next generation of Pre-Filled Syringes from design to manufacturing \nBuilding on the success of previous sell-out shows\, SMi Group is delighted to announce the return of the 5th annual conference and exhibition: Pre-Filled Syringes – East Coast\, taking place on April 11th – 12th 2018 in Boston\, Massachusetts\, USA. \n \nA rise in chronic diseases\, improvements in technology and a growing demand for easy to use drug administration products has in recent years\, created a booming Pre-Filled Syringes industry. \nSome notable areas of increased attention have been the broader trends for combination products and biologics\, as well as the move towards digital health and improving patient adherence due to increased self-administration figures. As well as these areas of lucrative opportunity\, there are still several ongoing challenges that the key-thought leaders are battling to overcome such as chemical compatibility\, user safety\, high-volume and highly viscous formulation\, and non-compliance. \nPre-Filled Syringes East Coast will once again play host to an international audience of drug delivery\, medical device and PFS experts to discuss emerging trends and offer innovative solutions to the challenges facing the prefilled industry\, helping attendees to secure global success for their PFS device. \nFeatured Speakers Include: \n– Dhairyamehta\, Associate Director of Device and Combination Products\, Shire\n– Stephen Barat\, Head of Pre-Clinical and Early Clinical Development\, Scynexis\n– Susan Neadle\, Head\, Combination Products Center of Excellence\, Sr. Director\, Quality Engineering & Design-to-Value\, Janssen Pharmaceuticals\n– Justin Wright\, Vice President\, Drug Delivery Innovation\, DDR&D Technology\, Eli Lilly\n– TiemingRuan\, Associate Director of Device Development\, Takeda\n– Molly Story\, Head\, Global Usability Engineering and Risk Management\, Sanofi\n– Gary Henniger\, R&D Director\, Discovery and Product Development R&D\, Teva\n– Michael Song\, Pharmaceutical Device and Digital Health\, Medimmune\n– Steve Bowman\, Device Program Lead\, Shire\n– Gary Mills\, Associate Director\, Drug Product Development\n– Kashappa Goud Desai\, Investigator\, Biopharmaceutical Product Sciences\, GlaxoSmithKline\n– Maria Linzmayer\, Associate Director\, Drug Delivery Devices\, Merck \nReasons to Attend: \n– Navigate through the regulatory landscape through guidance on compliance\n– Understand end-use interaction with delivery systems and Human Factor engineering\n– Receive insight on delivering high concentration formulations.\n– Integrate Quality-by-Design (QbD) principles for best practice solutions in developing your combination products.\n– Updates on new technologies\, including digital monitoring biomarkers from Eli Lilly; electronic enabled drug delivery devices from MedImmune; and PFS tech transfer of in-line products from Merck.\n– Hear the latest results from recent studies in chemical compatibility; comparison of COP vs glass; and container integrity.\n– Participate in our two interactive panel discussions and gain from over 5 hours of dedicated networking time. \nA snapshot of confirmed sponsors includes: Mitsubishi Gas Chemical\, Nemera\, NN\, Inc Precision Engineered Products\, SCHOTT\, Schreiner MediPharm\, Terumo Pharmaceutical Solutions\, Zeon \nFor more information or register\, visit http://www.pfsamericas.com/pjournalist \nTo get in touch\, contact Fateja Begum on Tel: +44 (0)20 7827 6184 / Email: fbegum@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/pre-filled-syringes-east-coast-2018/
LOCATION:Sheraton Boston Hotel\, 39 Dalton Street\, Boston\, MA\, 02199\, United States
ORGANIZER;CN="SMi Group Ltd":MAILTO:tarri@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180411
DTEND;VALUE=DATE:20180413
DTSTAMP:20260515T074216
CREATED:20180131T133231Z
LAST-MODIFIED:20180201T152133Z
UID:8955-1523404800-1523577599@www.pharmajournalist.com
SUMMARY:Asthma & COPD
DESCRIPTION:SMi is excited to announce the latest event in their Asthma & COPD series\, which returns to London on the 11th-12th April 2018. \nWith asthma and chronic obstructive pulmonary disorder (COPD) affecting about 500 million people worldwide\, opportunities in drug development are vast and reducing serious attacks by improving adherence could save $19 billion a year in U.S. healthcare costs* http://reut.rs/2xqyBjZ \nRecent advances in injectable biologics and smart medical devices as led to an increase in novel approaches to treating severe asthma and COPD as well as the regulations to take into consideration. As technology soars\, the need for guideline updates from regulators has increased and continues to be modified. \nJoin us as we discuss current clinical trials and the innovative digital technology being used to improve clinical adherence. Leading industry experts will be looking at the use of ‘real world data’ human factors in the design of medical devices and triple combination treatments on the market. We will also be looking at asthma and COPD Phenotyping and biomarker application and differences between in the EU and US for the approval of biologics. We will be exploring the complexities of dry powder formulation and helping you determine clinical efficacy and endpoints. \nTo learn more about this event\, and to register online\, visit www.asthma-copd.co.uk/pharmajourno
URL:https://www.pharmajournalist.com/event/asthma-copd/
LOCATION:Copthorne Tara Hotel\, London
ORGANIZER;CN="SMi Group Ltd":MAILTO:acaddick@smi-online.co.uk
END:VEVENT
END:VCALENDAR